USPTO serial 79201268
Serial No. 79201268
Reviewed by CopyMark Law Group
Reg. 5499785Status 709
- Filing date
- Status date
- Registration date
- Jun 26, 2018
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79201268?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Beth E. Cooperstein
Beth E. Cooperstein Holland & Hart LLPP.O. Box 8749Denver, CO 80201UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in science, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes; chemical products for use in the medical and pharmaceutical industries, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptides substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes | SECTION 71 - CANCELLED | — |
| 005 | Chemical products intended to be integrated in medicines so as to improve their effectiveness, namely, pharmaceutical excipients sold as an integral component of medicines so as to promote dissemination in a given area of the human body; pharmaceutical excipients, namely, drug delivery agents consisting of chemical compounds that improve delivery of a wide range of pharmaceuticals; pharmaceutical substances for medical use, namely for treatment of diabetes; pharmaceutical and veterinary products, namely for treatment of diabetes | SECTION 71 - CANCELLED | — |
| 042 | Medical research; scientific and technological services, namely, scientific analysis, scientific research and development and design and testing of new products for others, clinical research, all in the field of treatment of diabetes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 14, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 14, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 10, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 10, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 10, 2025 | C71T | CANCELLED SECTION 71 | — |
| Jun 26, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 19, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 28, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 28, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 26, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 26, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 10, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 10, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 6, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 21, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 21, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 21, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 6, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 6, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 6, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 15, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 15, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 11, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 17, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 17, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 16, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 10, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |